Essential Medicines List Implementation Dynamics: A Case Study Using Brazilian Federal Medicines Expenditures-Reference-Cited by-同舟云学术

Essential Medicines List Implementation Dynamics: A Case Study Using Brazilian Federal Medicines Expenditures

Published:2017-05-18 Issue:3 Volume:121 Page:181-188
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Magarinos-Torres Rachel¹²,Lynd Larry David²³,Luz Tatiana Chama Borges⁴⁵,Marques Paulo Eduardo Potyguara Coutinho⁶,Osorio-de-Castro Claudia Garcia Serpa⁷

Affiliation:

1. Faculty of Pharmacy; Federal University of the State of Rio de Janeiro (UFF); Niteroi Rio de Janeiro Brazil

2. Collaboration for Outcomes Research and Evaluation; Faculty of Pharmaceutical Sciences; University of British Columbia; Vancouver BC Canada

3. Centre for Health Evaluation and Outcome Sciences; Providence Health Care Research Institute; Vancouver BC Canada

4. René Rachou Research Center; Oswaldo Cruz Foundation; Belo Horizonte Minas Gerais Brazil

5. Department of Medicine; Clinical Epidemiology; Karolinska Institutet; Stockholm Sweden

6. Institute for Communication and Scientific and Technological Information; Oswaldo Cruz Foundation; Rio de Janeiro Brazil

7. Sergio Arouca National School of Public Health; Oswaldo Cruz Foundation; Rio de Janeiro Brazil

Funder

Brazil Ministry of Health

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcpt.12783/fullpdf

Reference51 articles.

1. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries;Mendis;Bull World Health Organ,2007

2. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis;Cameron;Lancet,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Public procurement of antineoplastic agents used for treating breast cancer in Brazil between 2013 and 2019;BMC Cancer;2022-07-15

2. National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis;PLOS Medicine;2022-03-11

3. Data Sources for Drug Utilization Research in Brazil—DUR-BRA Study;Frontiers in Pharmacology;2022-01-14

4. Tendência nos gastos com medicamentos neuropsiquiátricos em Minas Gerais, Brasil: há aumento da oferta de antiparkinsonianos?;Ciência & Saúde Coletiva;2021-08

5. Consumption and Lack of Access to Medicines and Associated Factors in the Brazilian Amazon: A Cross-Sectional Study, 2019;Frontiers in Pharmacology;2020-10-06